Therapeutic Targets for the Prevention of Type 1 Diabetes Mellitus

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 5, Iss. 2, 2005-06 ,pp. : 227-236

Bentham Science Publishers

Access to resources Recommend Favorite

The prevention of type 2 diabetes mellitus

By Davies Melanie J.  

Clinical Medicine, Vol. 3, Iss. 5, 2003-09 ,pp. : 470-474

Royal College Of Physicians

Access to resources Recommend Favorite

Insulin Detemir Results in Less Weight Gain than NPH Insulin When Used in Basal-Bolus Therapy for Type 2 Diabetes Mellitus, and this Advantage Increases with Baseline Body Mass Index

By Rašlová Katarina  

Clinical Drug Investigation, Vol. 27, Iss. 4, 2007-01 ,pp. : 279-285

Adis International

Access to resources Recommend Favorite

Height, body mass index (BMI), BMI change, and the risk of estrogen receptor-positive, HER2-positive, and triple-negative breast cancer among women ages 20 to 44 years

By Kawai Masaaki   Malone Kathleen E.   Tang Mei-Tzu C.   Li Christopher I.  

Cancer, Vol. 120, Iss. 10, 2014-05 ,pp. : 1548-1556

Blackwell Publishing

Access to resources Recommend Favorite

Orlistat: In the Prevention and Treatment of Type 2 Diabetes Mellitus

By Keating G.M.   Jarvis B.  

Drugs, Vol. 61, Iss. 14, 2001-01 ,pp. : 2107-2119

Adis International

Access to resources Recommend Favorite